Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 1858252, 10 pages
http://dx.doi.org/10.1155/2016/1858252
Research Article

Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor

1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China
2Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Diseases, Capital Medical University, Beijing 100069, China
3Department of Physiology, Basic Medical Department, Fenyang College of Shanxi Medical University, Fenyang, Shanxi 032200, China
4Department of Pathology, Shanxi Medical University, Taiyuan, Shanxi 030001, China
5Department of Emergency Medicine, Thomas Jefferson University, 1025 Walnut Street, College Building, Suite 808, Philadelphia, PA 19107, USA

Received 12 October 2015; Accepted 27 December 2015

Academic Editor: Xiao-Feng Yang

Copyright © 2016 Mingming Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and T. Unger, “International union of pharmacology. XXIII. The angiotensin II receptors,” Pharmacological Reviews, vol. 52, no. 3, pp. 415–472, 2000. View at Google Scholar · View at Scopus
  2. D. X. Liu, Y. Q. Zhang, B. Hu, J. Zhang, and Q. Zhao, “Association of AT1R polymorphism with hypertension risk: an update meta-analysis based on 28,952 subjects,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 16, no. 4, pp. 898–909, 2015. View at Publisher · View at Google Scholar
  3. A. C. Montezano, A. N. D. Cat, F. J. Rios, and R. M. Touyz, “Angiotensin II and vascular injury,” Current Hypertension Reports, vol. 16, article 431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. R. R. Blanco, H. Austin, R. N. Vest III et al., “Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failure,” Journal of Cardiac Failure, vol. 18, no. 9, pp. 717–723, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Yasuno, K. Kuwahara, H. Kinoshita et al., “Angiotensin II type 1a receptor signalling directly contributes to the increased arrhythmogenicity in cardiac hypertrophy,” British Journal of Pharmacology, vol. 170, no. 7, pp. 1384–1395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Welter, A. Huber, S. Lauf et al., “Angiotensin II regulates testicular peritubular cell function via AT1 receptor: a specific situation in male infertility,” Molecular and Cellular Endocrinology, vol. 393, no. 1-2, pp. 171–178, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Wenzel, A. Rajakumar, H. Haase et al., “Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats,” Hypertension, vol. 58, no. 1, pp. 77–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Bogdan, L. Schärer, R. Rüdlinger, and J. Hafner, “Epidermodysplasia verruciformis in two brothers developing aggressive squamous cell carcinoma,” Dermatologic Surgery, vol. 33, no. 12, pp. 1525–1528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Y. Ji, Z. D. Wang, S. F. Wang et al., “Ischemic preconditioning ameliorates intestinal injury induced by ischemia-reperfusion in rats,” World Journal of Gastroenterology, vol. 21, no. 26, pp. 8081–8088, 2015. View at Publisher · View at Google Scholar
  10. S. L. Zhang, R. H. Zheng, L. H. Yang et al., “Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction,” Journal of Cellular Physiology, vol. 228, no. 1, pp. 142–148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. L. Zhang, X. Zhang, L. H. Yang et al., “Increased susceptibility to metabolic syndrome in adult offspring of angiotensin type 1 receptor autoantibody-positive rats,” Antioxidants & Redox Signaling, vol. 17, no. 5, pp. 733–743, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Ma, K. Wang, J. Shang et al., “Anti-peroxynitrite treatment ameliorated vasorelaxation of resistance arteries in aging rats: involvement with NO-sGC-cGKs pathway,” PLoS ONE, vol. 9, no. 8, Article ID e104788, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. C. Zhou, Y. J. Zhang, R. A. Irani et al., “Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice,” Nature Medicine, vol. 14, no. 8, pp. 855–862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-P. Wang, W.-H. Zhang, X.-F. Wang et al., “Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats,” International Journal of Molecular Sciences, vol. 15, no. 7, pp. 11495–11509, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Yang, F. Wang, W. B. Lau et al., “Autoantibodies isolated from preeclamptic patients induce endothelial dysfunction via interaction with the angiotensin II AT1 receptor,” Cardiovascular Toxicology, vol. 14, no. 1, pp. 21–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. W. J. Li, Y. Q. Chen, S. H. Li et al., “Agonistic antibody to angiotensin ii type 1 receptor accelerates atherosclerosis in apoe−/− mice,” American Journal of Translational Research, vol. 6, no. 6, pp. 678–690, 2014. View at Google Scholar · View at Scopus
  17. L. Song, S.-L. Zhang, K.-H. Bai et al., “Serum agonistic autoantibodies against type-1 angiotensin II receptor titer in patients with epithelial ovarian cancer: a potential role in tumor cell migration and angiogenesis,” Journal of Ovarian Research, vol. 6, article 22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Yang, L. Li, J. Y. Shang et al., “Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia,” Journal of Hypertension, vol. 33, no. 5, pp. 1046–1056, 2015. View at Publisher · View at Google Scholar
  19. J. L. Gorman, S. T. K. Liu, D. Slopack et al., “Angiotensin II evokes angiogenic signals within skeletal muscle through co-ordinated effects on skeletal myocytes and endothelial cells,” PLoS ONE, vol. 9, no. 1, Article ID e85537, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Goupil, D. Fillion, S. Clément et al., “Angiotensin II type I and prostaglandin F2α receptors cooperatively modulate signaling in vascular smooth muscle cells,” The Journal of Biological Chemistry, vol. 290, no. 5, pp. 3137–3148, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Lin, C. Y. Tang, J. F. Xu et al., “Mechanical stress triggers cardiomyocyte autophagy through angiotensin II type 1 receptor-mediated p38MAP kinase independently of angiotensin II,” PLoS ONE, vol. 9, no. 2, Article ID e89629, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. G. P. Diniz, M. S. Carneiro-Ramos, and M. L. M. Barreto-Chaves, “Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3β/mTOR signaling pathway,” Basic Research in Cardiology, vol. 104, no. 6, pp. 653–667, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Xia and R. E. Kellems, “Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond,” Circulation Research, vol. 113, no. 1, pp. 78–87, 2013. View at Publisher · View at Google Scholar · View at Scopus